For endometriosis, the recommended dose of Lupron Depot is 3.75 mg monthly or 11.5 mg every 3 months. The recommended duration of treatment is 6 months.
Fibroids are treated with either a single 11.5 mg dose of Lupron Depot or 3.75 mg doses given monthly for up to 3 months.
The recommended starting dose of leuprolide for treating central precocious puberty is 50 mcg/kg/day. This dose can be increased by 10 mcg/kg/day depending on the response of the patient. Alternatively, Lupron Depot-Ped can be given at 7.5 mg (¡Ü25 kg), 11.25 mg (25 to 37.5 kg), or 15 mg (>37.5 kg) intramuscular injection once a month. Alternatively 11.25 mg or 30 mg single dose can be administered every 3 months.
DRUG INTERACTIONS: No drug interaction studies have been done for leuprolide.
PREGNANCY: Leuprolide should not be administered to pregnant women because there is a high chance of harm to the fetus.
NURSING MOTHERS: The effects of leuprolide on the infant have not been studied in women who are breastfeeding.
Medically reviewed by Eni Williams, PharmD
Reference: FDA Prescribing Information
Quick GuideProstate Cancer Symptoms, Treatment, and Survival Rates
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.